Bone marrow mesenchymal stem cells protect against renal ischemia reperfusion injury through paracrine mechanism

Hu Hong-lin,Wang Gong-xian,Zou Cong,Huang Xue-ming,Xi Xiao-qing,Shi Zi-min
DOI: https://doi.org/10.3969/j.issn.1673-8225.2011.32.024
2011-01-01
Abstract:BACKGROUND: Bone marrow mesenchymal stem cells (BMSCs) can be used in the animal experiments of renal ischemia reperfusion injury. OBJECTIVE: To explore the paracrine mechamism of BMSCs in treatment of renal ischemia reperfusion injury. METHODS: Rat BMSCs were isolated by percoll density gradient centrifugation and labeled with 4,6-diamidino-2-pheny-lindole (DAPI). Male SD rats were subjected to clamping renal pedicles for 45 minutes and divided randomly into the transplanted group and the control group. DAPI-labeled MSCs or saline were transplanted into the rats by inferior vena cava. Immunohistochemical method was used to detect the expression of vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF-α) in kidneys day 2 post-operation. RESULTS AND CONCLUSION: Compared with the control group, the serum creatinine and blood urine nitrogen in the transplanted group were significantly decreased at 1 and 2 days after operation (P < 0.05). At 3 days, the DAPI-positive cells could be found in the renal tissue in the transplanted group and significantly increased at 4 days(P < 0.05). The expression of VEGF was increased and the expression of TNF-α was decreased in kidneys in the transplanted group at 2 days by immunohistochemical method. BMSCs can protect against renal ischemia reperfusion injury through the paracrine mechamism.
What problem does this paper attempt to address?